Compare ISSC & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ISSC | XOMA |
|---|---|---|
| Founded | 1988 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 380.6M | 308.6M |
| IPO Year | 2000 | N/A |
| Metric | ISSC | XOMA |
|---|---|---|
| Price | $20.27 | $31.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $16.50 | ★ $60.60 |
| AVG Volume (30 Days) | ★ 772.5K | 101.5K |
| Earning Date | 05-13-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.63 | $24.95 |
| Revenue Next Year | $8.13 | $6.20 |
| P/E Ratio | $88.82 | ★ $29.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.30 | $18.40 |
| 52 Week High | $30.98 | $39.92 |
| Indicator | ISSC | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 36.31 | 68.68 |
| Support Level | $17.57 | $23.92 |
| Resistance Level | $22.60 | $30.79 |
| Average True Range (ATR) | 2.13 | 1.59 |
| MACD | -1.36 | 0.27 |
| Stochastic Oscillator | 11.69 | 86.00 |
Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.